| pubmed-article:16928711 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16928711 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
| pubmed-article:16928711 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:16928711 | lifeskim:mentions | umls-concept:C0221757 | lld:lifeskim |
| pubmed-article:16928711 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:16928711 | lifeskim:mentions | umls-concept:C0302350 | lld:lifeskim |
| pubmed-article:16928711 | lifeskim:mentions | umls-concept:C1705938 | lld:lifeskim |
| pubmed-article:16928711 | lifeskim:mentions | umls-concept:C2698651 | lld:lifeskim |
| pubmed-article:16928711 | lifeskim:mentions | umls-concept:C1527178 | lld:lifeskim |
| pubmed-article:16928711 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:16928711 | pubmed:dateCreated | 2006-11-20 | lld:pubmed |
| pubmed-article:16928711 | pubmed:abstractText | Exogenous doses of 60 mg/kg alpha(1)-antitrypsin (AAT) every 7 days are recommended in patients with severe AAT deficiency. However, long term administration of weekly doses is not well accepted by patients. Using pharmacokinetic simulations, we evaluated whether steady state minimum concentrations of total AAT can be maintained above the threshold of 0.5 g/l with longer intervals between doses. | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16928711 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16928711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928711 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16928711 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16928711 | pubmed:issn | 0040-6376 | lld:pubmed |
| pubmed-article:16928711 | pubmed:author | pubmed-author:TorresAA | lld:pubmed |
| pubmed-article:16928711 | pubmed:author | pubmed-author:de la RozaCC | lld:pubmed |
| pubmed-article:16928711 | pubmed:author | pubmed-author:LariJJ | lld:pubmed |
| pubmed-article:16928711 | pubmed:author | pubmed-author:SonKK | lld:pubmed |
| pubmed-article:16928711 | pubmed:author | pubmed-author:MiravitllesMM | lld:pubmed |
| pubmed-article:16928711 | pubmed:author | pubmed-author:EsquinasCC | lld:pubmed |
| pubmed-article:16928711 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16928711 | pubmed:volume | 61 | lld:pubmed |
| pubmed-article:16928711 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16928711 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16928711 | pubmed:pagination | 1059-64 | lld:pubmed |
| pubmed-article:16928711 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:16928711 | pubmed:meshHeading | pubmed-meshheading:16928711... | lld:pubmed |
| pubmed-article:16928711 | pubmed:meshHeading | pubmed-meshheading:16928711... | lld:pubmed |
| pubmed-article:16928711 | pubmed:meshHeading | pubmed-meshheading:16928711... | lld:pubmed |
| pubmed-article:16928711 | pubmed:meshHeading | pubmed-meshheading:16928711... | lld:pubmed |
| pubmed-article:16928711 | pubmed:meshHeading | pubmed-meshheading:16928711... | lld:pubmed |
| pubmed-article:16928711 | pubmed:meshHeading | pubmed-meshheading:16928711... | lld:pubmed |
| pubmed-article:16928711 | pubmed:meshHeading | pubmed-meshheading:16928711... | lld:pubmed |
| pubmed-article:16928711 | pubmed:meshHeading | pubmed-meshheading:16928711... | lld:pubmed |
| pubmed-article:16928711 | pubmed:meshHeading | pubmed-meshheading:16928711... | lld:pubmed |
| pubmed-article:16928711 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16928711 | pubmed:articleTitle | Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics. | lld:pubmed |
| pubmed-article:16928711 | pubmed:affiliation | Pharmacy Service, Hospital Clínic, (IDIBAPS), Barcelona, Spain. | lld:pubmed |
| pubmed-article:16928711 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16928711 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16928711 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16928711 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16928711 | lld:pubmed |
